CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale COO and Secretary sold 1,468 shares at an average $74.80 ($109,809)
- 4 Open-market sale CFO and Treasurer sold 1,448 shares at an average $74.68 ($108,135)
- 4 Open-market sale Chief Medical Officer sold 1,470 shares at an average $74.68 ($109,785)
- 4 Open-market sale President and CEO sold 5,112 shares at an average $73.79 ($377,211)
- 4 Open-market sale COO and Secretary sold 10,000 shares at an average $67.84 ($678,361)
- 4 Open-market sale President and CEO sold 18,334 shares at an average $68.44 ($1,254,819)
- 4 Open-market sale CFO and Treasurer sold 50,000 shares at an average $71.45 ($3,572,556)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale COO and Secretary sold 70,000 shares at an average $74.95 ($5,246,408)
- 4 Open-market sale President and CEO sold 88,334 shares at an average $74.96 ($6,621,782)
- 4 Open-market sale Director sold 30,000 shares at an average $90.05 ($2,701,582)
- 4 Other disposition 10% owner disposed of 383,411 shares (other)
- 4 Open-market sale 10% owner sold 64,624 shares at an average $80.14 ($5,179,285)
- 4/A Open-market sale Chief Medical Officer sold 17,500 shares at an average $19.44 ($340,168)
- 4/A Open-market sale Chief Medical Officer sold 17,500 shares at an average $18.45 ($322,834)
- 4/A Open-market sale Chief Medical Officer sold 17,500 shares at $18.07 ($316,157)
- 4/A Shares withheld for taxes COO and Secretary gave up 1,954 shares (to pay taxes)
Page 14 of 22 · 436 filings